As of Feb 16
| -0.09 / -0.19%|
The 15 analysts offering 12-month price forecasts for Metlife Inc have a median target of 55.00, with a high estimate of 60.00 and a low estimate of 46.00. The median estimate represents a +17.92% increase from the last price of 46.64.
The current consensus among 19 polled investment analysts is to Buy stock in Metlife Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.